{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:08:47Z","timestamp":1788869327487,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.beem.2026.102103","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:08:32Z","timestamp":1776874112000},"page":"102103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolactinoma diagnosis: Clinical, biochemical, and radiological considerations"],"prefix":"10.1016","volume":"40","author":[{"given":"Stephan","family":"Petersenn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2026.102103_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib2","first-page":"3","article-title":"Prolactin biology and laboratory measurement: an update on physiology and current analytical issues","volume":"39","author":"Saleem","year":"2018","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.beem.2026.102103_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2015.36","article-title":"New insights in prolactin: pathological implications","volume":"11","author":"Bernard","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2026.102103_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","article-title":"Hyperprolactinaemia and luteal insufficiency","volume":"1","author":"Sepp\u00e4l\u00e4","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2026.102103_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11102-025-01567-4","article-title":"Urinary incontinence as a novel and underrecognized clinical manifestation of prolactinoma in women","volume":"28","author":"Hep\u015fen","year":"2025","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/bs.vh.2024.11.001","article-title":"Hypogonadism in men with prolactinoma: diagnosis, treatment, and management of persistent hypogonadism","volume":"129","author":"Rudman","year":"2025","journal-title":"Vitam Horm"},{"key":"10.1016\/j.beem.2026.102103_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117532","article-title":"Prolactin impairs erectile function via eNOS suppression independently of testosterone","volume":"504","author":"Cheng","year":"2025","journal-title":"Toxicol Appl Pharm"},{"key":"10.1016\/j.beem.2026.102103_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cen.15120","article-title":"Visual morbidity in macroprolactinoma: a retrospective cohort study","volume":"101","author":"Rudman","year":"2024","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/andr.13428","article-title":"Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men","volume":"11","author":"Rudman","year":"2023","journal-title":"Andrology"},{"key":"10.1016\/j.beem.2026.102103_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12020-024-03880-7","article-title":"Muscle function, exercise capacity, physical activity level and cardiovascular disease risk factor knowledge in patients with prolactinoma","volume":"85","author":"Erko\u00e7","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102103_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/brainsci13010082","article-title":"Neuropsychological alterations of prolactinomas\u2019 cognitive flexibility in task switching","volume":"13","author":"Cao","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.beem.2026.102103_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11102-024-01392-1","article-title":"Quality of life in Prolactinoma: a systematic review","volume":"27","author":"Castle-Kirszbaum","year":"2024","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/07435800.2015.1135444","article-title":"Obesity and hypercholesterolemia in patients with prolactinomas: could DHEA-S and growth hormone be the missing link","volume":"41","author":"Peri\u0107","year":"2016","journal-title":"Endocr Res"},{"key":"10.1016\/j.beem.2026.102103_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1363939","article-title":"Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center","volume":"15","author":"Hofbauer","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.beem.2026.102103_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","article-title":"High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas","volume":"14","author":"Mazziotti","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12020-011-9462-5","article-title":"Vertebral fractures in males with prolactinoma","volume":"39","author":"Mazziotti","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102103_bib19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1515\/cclm-2016-0902","article-title":"Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia","volume":"55","author":"Overgaard","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.beem.2026.102103_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1479-828X.2011.01321.x","article-title":"Variation of female prolactin levels with menopausal status and phase of menstrual cycle","volume":"51","author":"Tanner","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.beem.2026.102103_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/46.4.551","article-title":"Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women","volume":"46","author":"Garde","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2026.102103_bib23","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","article-title":"Prolactin in response to acute psychosocial stress in healthy men and women","volume":"36","author":"Lennartsson","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.beem.2026.102103_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-014-0576-7","article-title":"Importance of cannulated prolactin test in the definition of hyperprolactinaemia","volume":"18","author":"Whyte","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4158\/EP-2020-0260","article-title":"Role of cannulated prolactin test in evaluation of hyperprolactinemia - a retrospective study","volume":"26","author":"Tsur","year":"2020","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2026.102103_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/11795514211025276","article-title":"Utility of cannulated prolactin to exclude stress hyperprolactinemia in patients with persistent mild hyperprolactinemia","volume":"14","author":"Almazrouei","year":"2021","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2026.102103_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1254\/jphs.92.171","article-title":"Macroprolactinemia: a new cause of hyperprolactinemia","volume":"92","author":"Hattori","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.beem.2026.102103_bib28","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1210\/jc.2010-0114","article-title":"Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant","volume":"95","author":"Wallace","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib29","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1210\/jc.2001-011943","article-title":"Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1373\/clinchem.2005.065854","article-title":"Specificity and clinical utility of methods for the detection of macroprolactin","volume":"52","author":"Kavanagh","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2026.102103_bib31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1373\/49.9.1504","article-title":"Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia","volume":"49","author":"Suliman","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2026.102103_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2008.105312","article-title":"Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms","volume":"54","author":"Beltran","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2026.102103_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/acb.2008.007233","article-title":"False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins","volume":"45","author":"Ram","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.beem.2026.102103_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11102-019-01024-z","article-title":"Biochemical diagnosis in prolactinomas: some caveats","volume":"23","author":"Petersenn","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s12020-020-02497-w","article-title":"Hypeprolactinemia: still an insidious diagnosis","volume":"72","author":"Aliberti","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102103_bib37","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2026.102103_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jalm\/jfz010","article-title":"AACC guidance document on biotin interference in laboratory tests","volume":"5","author":"Li","year":"2020","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.beem.2026.102103_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coemr.2019.06.012","article-title":"The thyroid axis, prolactin, and exercise in humans","volume":"9","author":"Hackney","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.beem.2026.102103_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00421-004-1223-1","article-title":"Relationship between stress hormones and testosterone with prolonged endurance exercise","volume":"93","author":"Daly","year":"2005","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.beem.2026.102103_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-008-0106-6","article-title":"Drugs and prolactin","volume":"11","author":"Molitch","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.181.1.49","article-title":"Sexual dysfunction in patients taking conventional antipsychotic medication","volume":"181","author":"Smith","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.beem.2026.102103_bib43","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.beem.2026.102103_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.beem.2026.102103_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/jcp.0b013e31815ac4e5","article-title":"Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives","volume":"27","author":"Byerly","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.beem.2026.102103_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hup.1116","article-title":"Hyperprolactinemia associated with psychotropics--a review","volume":"25","author":"Madhusoodanan","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.beem.2026.102103_bib47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(00)02697-0","article-title":"Galactorrhoea and hyperprolactinaemia associated with protease-inhibitors","volume":"356","author":"Hutchinson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2026.102103_bib48","first-page":"506","article-title":"Hyperprolactinemia and contraception: a prospective study","volume":"65","author":"Luciano","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2026.102103_bib49","first-page":"8","article-title":"Incidence of hyperprolactinemia during oral contraceptive therapy","volume":"55","author":"Reyniak","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2026.102103_bib50","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1210\/clinem\/dgab868","article-title":"Oral contraceptive and menopausal hormone therapy use and risk of pituitary adenoma: cohort and case-control analyses","volume":"107","author":"Cote","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0272-6386(85)80181-5","article-title":"Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis","volume":"6","author":"Hou","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2026.102103_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1978.tb02206.x","article-title":"Hyperprolactinaemia in renal disease","volume":"9","author":"Cowden","year":"1978","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/hdi.12489","article-title":"Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis","volume":"21","author":"Lo","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.beem.2026.102103_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.23.4.276","article-title":"Progesterone, prolactin, and gynaecomastia in men with liver disease","volume":"23","author":"Farthing","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.beem.2026.102103_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gut.19.3.170","article-title":"Serum prolactin in liver disease and its relationship to gynaecomastia","volume":"19","author":"Morgan","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.beem.2026.102103_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01308378","article-title":"Hyperprolactinemia in portal systemic encephalopathy","volume":"26","author":"McClain","year":"1981","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.beem.2026.102103_bib57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-2007-1009318","article-title":"Hyperprolactinemia in hepatic encephalopathy may result from impaired central dopaminergic neurotransmission","volume":"21","author":"Corenblum","year":"1989","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2026.102103_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0034-1375612","article-title":"Serum prolactin in advanced chronic liver disease","volume":"46","author":"Ress","year":"2014","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2026.102103_bib59","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.78.11.6662","article-title":"Thyrotropin-releasing hormone exerts rapid nuclear effects to increase production of the primary prolactin mRNA transcript","volume":"78","author":"Potter","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2026.102103_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/endo-107-1-85","article-title":"Effects of altered thyroid function on plasma prolactin clearance","volume":"107","author":"Cave","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2026.102103_bib61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/endo-115-1-407","article-title":"Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding","volume":"115","author":"Foord","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2026.102103_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1677\/joe.0.1090359","article-title":"Tri-iodothyronine and phenytoin reduce prolactin messenger RNA levels in cultured rat pituitary cells","volume":"109","author":"Davis","year":"1986","journal-title":"J Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib63","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1507\/endocrj.K10E-215","article-title":"The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism","volume":"57","author":"Hekimsoy","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2026.102103_bib64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2016.07.012","article-title":"Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism","volume":"35","author":"Sharma","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.beem.2026.102103_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2265.2003.01694.x","article-title":"Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization","volume":"58","author":"Raber","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2026.102103_bib66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0015-0282(16)48872-2","article-title":"Hyperprolactinemia in primary adrenocortical insufficiency","volume":"44","author":"Kelver","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2026.102103_bib67","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/jcem-45-5-931","article-title":"Galactorrhea and hyperprolactinemia associated with chest wall injury","volume":"45","author":"Morley","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib68","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3171\/2014.9.JNS132687","article-title":"Hyperprolactinemia due to spontaneous intracranial hypotension","volume":"122","author":"Schievink","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beem.2026.102103_bib69","article-title":"Magnetic resonance imaging in\u00a0the management of prolactinomas; a review of the evidence","author":"Varlamov","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib70","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11102-024-01430-y","article-title":"Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants","volume":"27","author":"van Trigt","year":"2024","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib71","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41598-021-89256-7","article-title":"Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis","volume":"11","author":"Leca","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102103_bib72","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0054","article-title":"Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review","volume":"14","author":"Lu","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2026.102103_bib73","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1210\/jc.2005-0288","article-title":"Primary empty sella","volume":"90","author":"De Marinis","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102103_bib74","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinte.1983.00350070103017","article-title":"Coexistent primary empty sella syndrome and hyperprolactinemia. Report of 11 cases","volume":"143","author":"Gharib","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2026.102103_bib75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen.13156","article-title":"The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS)","volume":"86","author":"Soto-Pedre","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2026.102103_bib76","first-page":"1039","article-title":"Reproductive function and pregnancy outcomes in women treated for idiopathic hyperprolactinemia: a non-randomized controlled study","volume":"18","author":"Sokhadze","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.beem.2026.102103_bib77","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s12020-021-02624-1","article-title":"True hyperprolactinemia in men without visible pituitary adenoma","volume":"72","author":"Shimon","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102103_bib78","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2017.7462","article-title":"Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas","author":"Huang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.beem.2026.102103_bib79","first-page":"1","article-title":"Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size","author":"Burke","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beem.2026.102103_bib80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","article-title":"Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas","volume":"74","author":"Wright","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102103_bib81","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/j.wneu.2021.12.074","article-title":"Serum prolactin level to tumor size ratio as a potential parameter for preoperative differentiation of prolactinomas from hyperprolactinemia-causing non-functional pituitary adenomas","volume":"159","author":"Kim","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2026.102103_bib82","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF03347299","article-title":"Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect","volume":"21","author":"Petakov","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2026.102103_bib83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1025334001748","article-title":"Falsely low serum prolactin in two cases of invasive macroprolactinoma","volume":"5","author":"Sch\u00f6fl","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib84","first-page":"78","article-title":"The \u2018hook effect\u2019 on serum prolactin estimation in a patient with macroprolactinoma","volume":"49","author":"Unnikrishnan","year":"2001","journal-title":"Neurol India"},{"key":"10.1016\/j.beem.2026.102103_bib85","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006123-199804000-00126","article-title":"Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the \u201chigh-dose hook effect\u201d: case report","volume":"42","author":"Barkan","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2026.102103_bib86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11102-022-01246-8","article-title":"Prolactin immunoassay: does the high-dose hook effect still exist","volume":"25","author":"Raverot","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102103_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102103_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12020-019-02029-1","article-title":"Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up","volume":"66","author":"Lv","year":"2019","journal-title":"Endocrine"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:19:45Z","timestamp":1788866385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521690X26000242"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102103","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactinoma diagnosis: Clinical, biochemical, and radiological considerations","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102103"}}